OncoDNA is a Belgium-based company founded in December 2012 focusing on precision medicine in oncology. The company aims to provide cancer molecular profiling to individualize therapy decisions. In September 2016, OncoDNA raised EUR 7.7 million in private equity. The new shares were subscribed by both the historical shareholders (IPG/bio.be, Invest4OncoDNA, Sambrinvest, and Vinsovier) as well as a group of four new investors (Sofinim NV, an affiliate of Ackermans & van Haaren, SRIW, CPH, and Inventures). In 2015, the company was recognized by Ernst & Young in Belgium as the "Promising Enterprise of the Year," a category in their "Entrepreneurs of the Year" awards. The company was also awarded Most Disruptive Innovator of 2015 by Deloitte’s Fast 50 jury. More information...
According to PR-model, oncodna.com is ranked 2,261,317th in multilingual Wikipedia, in particular this website is ranked 259,326th in French Wikipedia.
The website is placed before belljar.net and after flcivilrightshalloffame.com in the BestRef global ranking of the most important sources of Wikipedia.
